首页> 外文期刊>Experimental & Molecular Pathology >Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas
【24h】

Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas

机译:口腔鳞状细胞癌中APOBEC3B mRNA和蛋白表达的证据

获取原文
获取原文并翻译 | 示例
       

摘要

It has been demonstrated that APOBEC3B possesses cytidine deaminase activity, which is likely to result in C-to-T signature mutations. Increased expression of the APOBEC3B gene has been shown to correlate with higher incidence of such mutations in various cancer types, such as breast, bladder, lung, and head and neck carcinomas. In the current study, we used in silico methods, immunohistochemistry and qRT-PCR to detect the presence of APOBEC3B signature mutations and examine the levels and patterns of APOBEC3B expression in oral squamous cell carcinomas (OSCCs). Using the Cancer Genome Atlas (TCGA) database, we have found a high incidence of C-to-T transitions in head and neck squamous cell carcinomas (HNSCCs), of which OSCCs constitute the largest subgroup. Additionally, we compared APOBEC3B expression, at both mRNA and protein level, between OSCCs and non-cancerous samples. APOBEC3B was detected in both groups, but nuclear localization was consistent only in normal oral cells. APOBEC3B mRNA levels were clearly higher in OSCCs than in controls. These results suggest that while in normal oral cells APOBEC3B has an important nuclear function to fulfill, this activity may be hindered in a subgroup of tumor cells, due to the more prominent localization of the enzyme in the cytoplasm. (C) 2016 Elsevier Inc. All rights reserved.
机译:已经证明APOBEC3B具有胞苷脱氨酶活性,这很可能导致C-T标记突变。已显示APOBEC3B基因表达的增加与各种癌症类型(例如乳腺癌,膀胱癌,肺癌和头颈癌)中此类突变发生率更高相关。在本研究中,我们采用计算机模拟方法,免疫组织化学和qRT-PCR检测APOBEC3B标志突变的存在,并检查口腔鳞状细胞癌(OSCC)中APOBEC3B表达的水平和模式。使用癌症基因组图谱(TCGA)数据库,我们发现头颈部鳞状细胞癌(HNSCC)中C到T转换的发生率很高,其中OSCC构成最大的亚组。此外,我们比较了OSCC和非癌性样品在mRNA和蛋白水平上APOBEC3B的表达。两组均检测到APOBEC3B,但核定位仅在正常口腔细胞中是一致的。 OSCC中的APOBEC3B mRNA水平明显高于对照组。这些结果表明,尽管在正常的口腔细胞中,APOBEC3B具有重要的核功能,但由于该酶在细胞质中的定位更为突出,因此在肿瘤细胞亚群中这种活性可能受到阻碍。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号